Inozyme Pharma Announces Dosing of First Patient in First-in-Human Clinical Trial of INZ-701 in Patients with ENPP1 Deficiency by Carolyn Helms | Nov 15, 2021 | Portfolio News
Cohere Health Wins TripleTree iAward for Innovative Healthcare Technology by Carolyn Helms | Nov 15, 2021 | Portfolio News
89bio Presents New Data from Phase 1b/2a NASH Study Showing BIO89-100 Reduces Spleen Volume by Carolyn Helms | Nov 14, 2021 | Portfolio News
Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update by Carolyn Helms | Nov 12, 2021 | Portfolio News
Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results by Carolyn Helms | Nov 11, 2021 | Portfolio News
